MedRx Co., Ltd

4586.T
Drug Manufacturers - Specialty & Generic
2026/10/30 18:57 Updated
Market Cap: $19.8M (¥3.1B)
Stock Price: $0.30 (¥47)
Exchange Rate: 1 USD = ¥157.48

Notice on Monthly Exercise Status of the 35th Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)

Published the monthly exercise status for October 2026 of the 35th stock acquisition rights. Number of shares granted: 1,299,900 shares; stock acquisition rights exercised in October: 12,999 units; proportion to total issued: 8.79%; unexercised stock acquisition rights at month-end: 28,396 units (2,839,600 shares).

Importance:
Page Updated: November 2, 2026
IR Disclosure Date: November 2, 2026

Key Figures

  • Number of shares granted: 1,299,900 shares
  • Number of stock acquisition rights exercised: 12,999 units
  • Unexercised stock acquisition rights (month-end): 28,396 units

AI要約

Exercise Status of Stock Acquisition Rights

This report summarizes the monthly exercise status for October 2026 of stock acquisition rights issued by third-party allotment. There were exercises on multiple days in October, totaling 12,999 stock acquisition rights exercised, and no transferred treasury shares occurred. The number of shares granted in the relevant month was 1,299,900 shares, indicating a large allotment, and the number of unexercised rights at month-end was 28,396 units. The exercise ratio relative to total issued is 8.79%, and the ratio relative to the exchange rules' exercise restriction is 2.19%.

Impact and Future Points of Attention

The exercise trend is progressing at a steady pace, and it is necessary to note that a substantial number of unexercised rights remain. Depending on future exercise trends, there is potential for dilution effects on treasury shares and changes in the number of outstanding shares. This disclosure is positioned as part of routine monitoring of exercise status.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

MedRx Co., Ltd

Company overview · Stock price · Financial data · All IR

View company page →